CV Advisors’s AbbVie ABBV Stock Holding History

CV Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$906K	Buy	+3,600	New	+$775K	0.17%	62

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

CV Advisors's ABBV Position: Q2 2026 in Review

CV Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 3,600 shares worth $906K. The stake represents 0.17% of the portfolio and ranks #62 among its holdings.

1,114 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

CV Advisors held 3,600 shares of AbbVie worth $906K as of Q2 2026.
AbbVie was a new CV Advisors position in Q2 2026.
AbbVie made up 0.17% of CV Advisors's portfolio in Q2 2026, its #62 holding.
1,114 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CV Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.